Veraxa Biotech AG (VRXA)
NASDAQ
$1.40−$0.0100 (−0.71%) on the dayAs of the close; data may be delayed.
VRXA price, last 12 months
Key stats
- Previous close
- $1.41
- Open
- $1.35
- Day range
- $1.35 – $1.48
- 52-week range
- $1.27 – $27.36
- Volume
- 47.4K
- Avg volume (20 days)
- 345.8K
- Market cap
- $199.4M
Performance
1W−4.1%
1M−14.6%
3M−39.7%
6M—
YTD—
1Y—
Technicals and fundamentals
About Veraxa Biotech AG
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
- Listed on
- NASDAQ
- Market cap
- $199.4M